Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists. 1993

D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan.

The effects of repeated amphetamine treatment on single antidromically identified nigrostriatal dopamine-containing (NSDA) neurons were evaluated in rats. The inhibitory potency and efficacy of dopamine (DA) agonists on NSDA neuron spontaneous discharge rate were examined after amphetamine treatment. Repeated amphetamine treatment (14 days, 1 or 6 mg/kg/day i.p.) dose-dependently decreased the sensitivity of NSDA neurons to the inhibitory effects of the i.v. administered quinpirole. The amphetamine-induced alteration in sensitivity to apomorphine and quinpirole was abolished by acute hemitransection of the forebrain/midbrain connections. No change in the responsiveness or sensitivity of NSDA neurons to the inhibitory effects of iontophoretically applied DA was detected after amphetamine treatment for 14 days (4 or 6 mg/kg/day) or 28 days (6 mg/kg/day). These results suggest that these amphetamine regimens alter the sensitivity/responsiveness of forebrain DA receptors but not NSDA cell somatodendritic DA autoreceptors in a dose-dependent manner.

UI MeSH Term Description Entries
D008297 Male Males
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001058 Apomorphine A derivative of morphine that is a dopamine D2 agonist. It is a powerful emetic and has been used for that effect in acute poisoning. It has also been used in the diagnosis and treatment of parkinsonism, but its adverse effects limit its use. Apokinon,Apomorphin-Teclapharm,Apomorphine Chloride,Apomorphine Hydrochloride,Apomorphine Hydrochloride Anhydrous,Apomorphine Hydrochloride, Anhydrous,Apomorphine Hydrochloride, Hemihydrate,Britaject,Apomorphin Teclapharm
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras

Related Publications

D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
June 2000, Synapse (New York, N.Y.),
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
May 1997, The Journal of pharmacology and experimental therapeutics,
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
July 1987, The Journal of pharmacology and experimental therapeutics,
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
March 1979, Psychopharmacology,
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
June 1995, Behavioral neuroscience,
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
January 1990, Synapse (New York, N.Y.),
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
July 2002, Journal of neurophysiology,
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
November 2013, Neurotoxicity research,
D K Pitts, and M D Kelland, and A S Freeman, and L A Chiodo
May 1990, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!